Edp-305, A Novel And Highly Potent Farnesoid X Receptor Agonist, Improves Liver Steatosis, Ballooning And Non-Alcoholic Fatty Liver Disease (Nafld) Activity Score (Nas) In A Diet-Induced Murine Model Of Non-Alcoholic Steatohepatitis
JOURNAL OF HEPATOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要